Search Results - "Bencomo‐Alvarez, Alfonso E."

Energy metabolism and drug response in myeloid leukaemic stem cells by Bencomo‐Alvarez, Alfonso E., Rubio, Andres J., Gonzalez, Mayra A., Eiring, Anna M.

“…Summary Despite significant advances in the treatment of myeloid malignancies, many patients become resistant to therapy and ultimately succumb to their…”
Get full text

Ethnic and border differences on blood cancer presentation and outcomes: A Texas population‐based study by Bencomo‐Alvarez, Alfonso E., Gonzalez, Mayra A., Rubio, Andres J., Olivas, Idaly M., Lara, Joshua J., Padilla, Osvaldo, Orazi, Attilio, Corral, Javier, Philipovskiy, Alexander, Gaur, Sumit, Mulla, Zuber D., Dwivedi, Alok K., Eiring, Anna M.

“…Background The Texas/Chihuahua (US/Mexico) border is a medically underserved region with many reported barriers for health care access. Although Hispanic…”
Get full text

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B by Bencomo-Alvarez, Alfonso E., Rubio, Andres J., Olivas, Idaly M., Gonzalez, Mayra A., Ellwood, Rebecca, Fiol, Carme Ripoll, Eide, Christopher A., Lara, Joshua J., Barreto-Vargas, Christian, Jave-Suarez, Luis F., Nteliopoulos, Georgios, Reid, Alistair G., Milojkovic, Dragana, Druker, Brian J., Apperley, Jane, Khorashad, Jamshid S., Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have revolutionized therapy for chronic myeloid leukemia (CML), paving the way for clinical development in…”
Get full text

19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML) by Lara, Joshua J, Bencomo-Alvarez, Alfonso E, Gonzalez, Mayra A, Olivas, Idaly M, Young, James E, Lopez, Jose L, Velazquez, Vanessa V, Glovier, Steven, Keivan, Mehrshad, Rubio, Andres J, Dang, Sara K, Solecki, Jonathan P, Allen, Jesse C, Tapia, Desiree N, Tychhon, Boranai, Astudillo, Gonzalo E, Jordan, Connor, Chandrashekar, Darshan S, Eiring, Anna M

“…26S proteasome non-ATPase subunits 1 (PSMD1) and 3 (PSMD3) were recently identified as prognostic biomarkers and potential therapeutic targets in chronic…”
Get full text

Racial/ethnic differences in the clinical presentation and survival of breast cancer by subtype by Nhim, Vutha, Bencomo-Alvarez, Alfonso E, Alvarado, Luis, Kilcoyne, Michelle, Gonzalez-Henry, Mayra A, Olivas, Idaly M, Keivan, Mehrshad, Gaur, Sumit, Mulla, Zuber D, Dwivedi, Alok K, Gadad, Shrikanth S, Eiring, Anna M

“…Breast cancer (BC) affects racial and ethnic groups differently, leading to disparities in clinical presentation and outcomes. It is unclear how Hispanic…”
Get full text

26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy by Rubio, Andres J., Bencomo-Alvarez, Alfonso E., Young, James E., Velazquez, Vanessa V., Lara, Joshua J., Gonzalez, Mayra A., Eiring, Anna M.

“…Ever since the ubiquitin proteasome system was characterized, efforts have been made to manipulate its function to abrogate the progression of cancer. As a…”
Get full text

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism by Gonzalez, Mayra A., Olivas, Idaly M., Bencomo‐Alvarez, Alfonso E., Rubio, Andres J., Barreto‐Vargas, Christian, Lopez, Jose L., Dang, Sara K., Solecki, Jonathan P., McCall, Emily, Astudillo, Gonzalo, Velazquez, Vanessa V., Schenkel, Katherine, Reffell, Kelaiah, Perkins, Mariah, Nguyen, Nhu, Apaflo, Jehu N., Alvidrez, Efren, Young, James E., Lara, Joshua J., Yan, Dongqing, Senina, Anna, Ahmann, Jonathan, Varley, Katherine E., Mason, Clinton C., Eide, Christopher A., Druker, Brian J., Nurunnabi, Md, Padilla, Osvaldo, Bajpeyi, Sudip, Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR::ABL1 have turned chronic myeloid leukaemia (CML) from a fatal disease into a manageable condition for most…”
Get full text

Blood cancer health disparities in the United States Hispanic population by Bencomo-Alvarez, Alfonso E, Rubio, Andres J, Gonzalez, Mayra A, Eiring, Anna M

“…Cancer is a challenging, multifaceted disease that involves a combination of biological and nonbiological factors. Aside from COVID-19, cancer is the second…”
Get full text

Abstract PO-200: Border differences on breast cancer incidence and survival between non-Hispanic white and Hispanic patients: A Texas population-based study by Nhim, Vutha, Bencomo-Alvarez, Alfonso E., Dwivedi, Alok K., Gadad, Shrikanth S., Eiring, Anna M.

“…Background: Breast cancer (BC) is the leading cause of cancer related deaths in Hispanic women. Hispanics make up an estimated 82% of the US/Mexico border, a…”
Get full text

Abstract P150: PSMD1 and PSMD3 as putative targets for cancer therapy by Rubio, Andres J., Bencomo-Alvarez, Alfonso E., Young, James E., Velazquez, Vanessa V., Eiring, Anna M.

“…Ever since the ubiquitin proteasome system was characterized, efforts have been made to manipulate its function to abrogate the progression of cancer. As a…”
Get full text

Proteasome 26S subunit, non-ATPases 1 , play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B by Bencomo-Alvarez, Alfonso E, Rubio, Andres J, Olivas, Idaly M, Gonzalez, Mayra A, Ellwood, Rebecca, Fiol, Carme Ripoll, Eide, Christopher A, Lara, Joshua J, Barreto-Vargas, Christian, Jave-Suarez, Luis F, Nteliopoulos, Georgios, Reid, Alistair G, Milojkovic, Dragana, Druker, Brian J, Apperley, Jane, Khorashad, Jamshid S, Eiring, Anna M

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have revolutionized therapy for chronic myeloid leukemia (CML), paving the way for clinical development in…”
Get full text

Abstract C066: Effects of race, ethnicity, and country of origin on incidence and survival in breast cancer by Bencomo-Alvarez, Alfonso E., Nhim, Vutha, Alvarado, Luis, Gonzalez, Mayra A., Kilcoyne, Michelle, Dwivedi, Alok K., Gadad, Shrikanth S., Eiring, Anna M.

“…Purpose: Breast cancer (BC) is the leading cause of cancer related deaths in Hispanic women. Hispanics make up an estimated 82% of the U.S./Mexico border, a…”
Get full text